We provide you with 20 years of free, institutional-grade data for DFFN stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of DFFN. Explore the full financial landscape of DFFN stock.
| Reported Date | CIK | Ticker | Type |
|---|
Diffusion Pharmaceuticals Inc(NASDAQ:DFFN) 
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. The c...
Website: http://www.diffusionpharma.com
Founded: 2001
Full Time Employees: 10
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about DFFN stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.